- Ensartinib (X-396) Effectively Modulates Pharmacokinetic Resistance Mediated by ABCB1 and ABCG2 Drug Efflux Transporters and CYP3A4 Biotransformation Enzyme2020 | Faculty of Pharmacy in Hradec Králové
- Lorlatinib in the treatment of non-small cell lung cancer2019 | Second Faculty of Medicine
- Strategie léčby ALK-pozitivního NSCLC2018 | Second Faculty of Medicine